An article from the Philadelphia Inquirer reports that twenty years after the first discoveries of BRCA1/2, men who carry one of the faulty genes are now becoming a focus of research and support. In men, both faulty genes raise breast cancer risk, with BRCA2 conferring a seven percent lifetime chance. Normally, a man's risk is remote - one-tenth of a percent, or 1 in 1,000. "Men very much matter in this equation," Jacquelyn Powers, a genetic counselor at Penn's Basser Research Center for BRCA in the Abramson Cancer Center, said during a presentation at the recent FORCE conference in Philadelphia.
Philadelphia Inquirer article